I am sure management will provide clarity soon. Management is not incompetent. After all, they were smart enough to acquire 6.3 million+ shares of Biohaven at rock bottom prices. Additionally, they also have positions in other companies like Sentien which just announced enrollment for their drug. Sentien is a very promising company imo that is not even being mentioned. I think the disconnect is from many investors not understanding/realizing the connection between PTGEF and Biohaven and some unsure of what management will do with the large amount of shares they are holding. Honestly, i would like to see a small reverse split (1/10 or 1/20), and either a disposition of biohaven shares whereby shareholders would get biohaven shares via a dividend (ptgef would then drop to a lower level now that they no longer have biohaven shares and then management can rebuild again by investing in other companies) and/or selling a few million biohaven shares, give us a little dividend and then use the rest of the money to buy into other companies. Just selling 1-2 million shares could get them about $30-$50 million in cash. I am sure they would put it to good use.
News 
Market Data 
Discover 
